Amod A. Sarnaik

Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma

Jeffrey S. Weber, Ragini R. Kudchadkar, Bin Yu et al. · Journal of Clinical Oncology · 2013 · 530 citations · Full text

Life Sciences, Immunology, Oncology +15

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

David Woods, Andressa L. Sodré, Alejandro Villagra et al. · Cancer Immunology Research · 2015 · 434 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Ben Creelan, Chao Wang, Jamie K. Teer et al. · Nature Medicine · 2021 · 421 citations · Full text

Medicine, Immunology, Oncology +16

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani et al. · Journal of Clinical Oncology · 2021 · 410 citations · Full text

Life Sciences, Immunology, Oncology +17

beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.

Wilson M. Clements, Jiang Wang, Amod A. Sarnaik et al. · PubMed · 2002 · 364 citations

Medicine, Genetics, Oncology +16